Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress and perspectives of systemic anticancer treatment.

B A Chabner, E Reed

    Nouvelle Revue Francaise D'Hematologie
    |January 1, 1986
    PubMed
    Summary

    Cancer chemotherapy is advancing beyond DNA synthesis inhibitors to target diverse cellular factors. Understanding drug resistance mechanisms is crucial for improving cancer treatment outcomes and developing novel therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.

    Biochemical pharmacology·2010
    Same author

    SU5416 sensitizes ovarian cancer cells to cisplatin through inhibition of nucleotide excision repair.

    Cellular and molecular life sciences : CMLS·2003
    Same author

    Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation.

    Bone marrow transplantation·2003
    Same author

    Malignant ascites as only manifestation of metastatic prostate cancer.

    Prostate cancer and prostatic diseases·2002
    Same author

    Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.

    Cellular and molecular biology (Noisy-le-Grand, France)·2002
    Same author

    An ERCC1 splicing variant involving the 5'-UTR of the mRNA may have a transcriptional modulatory function.

    Oncogene·2001

    Area of Science:

    • Molecular biology
    • Cancer research
    • Pharmacology

    Background:

    • Cancer chemotherapy is evolving from DNA synthesis inhibition to targeting various cellular factors.
    • These factors include growth factor response, cell membrane antigens, differentiation/proliferation signals, and cytotoxic recognition.

    Purpose of the Study:

    • To understand the molecular events causing drug resistance in cancer chemotherapy.
    • To explore new therapeutic strategies by investigating differences in resistance mechanisms.

    Main Methods:

    • Analyzing molecular events underlying drug resistance.
    • Investigating distinct resistance mechanisms for antimetabolites versus alkylating agents.
    • Utilizing screening systems with therapy-resistant human tumors for drug discovery.

    Main Results:

    • Drug resistance mechanisms can differ significantly between antimetabolites and alkylating agents.
    • Multiple resistance mechanisms often coexist within the same cancer cells.
    • Early-stage tumor treatment offers the highest probability of cure.

    Conclusions:

    • Advances in understanding drug resistance are critical for improving cancer cure rates.
    • New drug discovery efforts focus on therapy-resistant tumors to overcome resistance.
    • Targeting diverse cellular factors and resistance mechanisms holds promise for effective cancer treatment.

    Related Experiment Videos